Pulsenmore (PLSM) Cash & Equivalents (2025)
Pulsenmore's (PLSM) quarterly Cash & Equivalents came in at $6.8 million in Q4 2025.
Pulsenmore (PLSM) Cash & Equivalents (2025) Analysis & Trends
Pulsenmore has disclosed Cash & Equivalents across 1 years of filings, most recently posting $6.8 million for Q4 2025.
- Cash & Equivalents for Q4 2025 came in at $6.8 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $6.8 million (changed N/A YoY), and the FY2025 annual result was $6.8 million, changed N/A from the prior year.
- Cash & Equivalents came in at $6.8 million for Q4 2025 at Pulsenmore.
- In the past five years, Cash & Equivalents ranged from a high of $6.8 million in Q4 2025 to a low of $6.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.03 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1.12 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 439.60 Mn |
| 10 | Pulsenmore | 2.29 Mn | -19.38 Mn | - | 6.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.77 Mn |